AVTAR S DHILLON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for AVTAR S DHILLON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of AVTAR S DHILLON. AVTAR S DHILLON is Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and President & CEO in INOVIO PHARMACEUTICALS, INC. ($GEB) and Director in Vitality Biopharma, Inc. ($STVF) and Director in ONCOSEC MEDICAL Inc ($ONCS.D) and Director in Nemus Bioscience, Inc. ($NMUS) and Director in Arch Therapeutics, Inc. ($ARTH).
Latest Insider Trading Transactions of AVTAR S DHILLON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARTH, GEB, ONCS, NMUS, VBIO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 2020 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Grant | A | 1.55 | 12,500 | 19,375 | 62,052 | 49.6 K to 62.1 K (+25.23 %) |
| Apr 21 2020 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Grant | A | 1.55 | 12,500 | 19,375 | 62,052 | 49.6 K to 62.1 K (+25.23 %) |
| Jan 04 2019 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.66 | 50,000 | 32,750 | 50,000 | |
| Dec 06 2018 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | M | 2.00 | 25,000 | 50,000 | 0 | |
| Dec 06 2018 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Buy | M | 2.00 | 25,000 | 50,000 | 106,002 | 81 K to 106 K (+30.86 %) |
| Oct 12 2018 | NMUS | Nemus Bioscience, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.31 | 1,000,000 | 305,000 | 1,000,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.43 | 220,000 | 93,500 | 220,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Grant | A | 0.00 | 220,000 | 0 | 8,517,373 | 8.3 M to 8.5 M (+2.65 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.31 | 3,100 | 4,067 | 143,427 | 146.5 K to 143.4 K (-2.12 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.38 | 1,066 | 1,471 | 146,527 | 147.6 K to 146.5 K (-0.72 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.40 | 1,556 | 2,180 | 147,593 | 149.1 K to 147.6 K (-1.04 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.37 | 3,451 | 4,742 | 149,149 | 152.6 K to 149.1 K (-2.26 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.40 | 4,703 | 6,575 | 152,600 | 157.3 K to 152.6 K (-2.99 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.41 | 202 | 284 | 157,303 | 157.5 K to 157.3 K (-0.13 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.42 | 2,956 | 4,192 | 157,505 | 160.5 K to 157.5 K (-1.84 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.40 | 2,178 | 3,051 | 160,461 | 162.6 K to 160.5 K (-1.34 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.42 | 10,973 | 15,604 | 162,639 | 173.6 K to 162.6 K (-6.32 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.36 | 1,838 | 2,507 | 173,612 | 175.5 K to 173.6 K (-1.05 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Sell | S | 1.39 | 5,552 | 7,695 | 175,450 | 181 K to 175.5 K (-3.07 %) |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Buy | M | 0.00 | 100,000 | 0 | 181,002 | 81 K to 181 K (+123.45 %) |
| May 14 2018 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | M | 0.00 | 7,669 | 0 | 0 | |
| May 14 2018 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.00 | 8,170 | 0 | 8,170 | |
| May 14 2018 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | A | 4.56 | 12,500 | 57,000 | 12,500 | |
| May 14 2018 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Buy | M | 0.00 | 7,669 | 0 | 81,002 | 73.3 K to 81 K (+10.46 %) |
| Feb 09 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | A | 1.64 | 350,000 | 574,000 | 647,916 | |
| May 15 2017 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| May 15 2017 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | A | 7.14 | 12,500 | 89,250 | 12,500 | |
| May 15 2017 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.00 | 7,669 | 0 | 7,669 | |
| May 15 2017 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Buy | M | 0.00 | 10,000 | 0 | 73,333 | 63.3 K to 73.3 K (+15.79 %) |
| Mar 31 2017 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | A | 1.34 | 20,000 | 26,800 | 297,916 | |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.65 | 400,000 | 260,000 | 400,000 | |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Grant | A | 0.00 | 400,000 | 0 | 8,297,373 | 7.9 M to 8.3 M (+5.06 %) |
| Dec 16 2016 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | A | 1.29 | 265,416 | 342,387 | 265,416 | |
| Dec 16 2016 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | D | 5.76 | 500,000 | 2,880,000 | 0 | |
| Dec 16 2016 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | D | 7.60 | 12,500 | 95,000 | 0 | |
| Dec 16 2016 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | D | 16.10 | 12,500 | 201,250 | 0 | |
| Dec 16 2016 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | D | 5.00 | 5,000 | 25,000 | 0 | |
| Dec 16 2016 | ONCS | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | D | 4.20 | 5,000 | 21,000 | 0 | |
| Aug 17 2016 | STVF | Vitality Biopharma ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.00 | 925,585 | 0 | 1,015,585 | |
| Aug 17 2016 | STVF | Vitality Biopharma ... | DHILLON AVTAR S | Director | Option Exercise | A | 2.10 | 40,000 | 84,000 | 90,000 | |
| May 16 2016 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | A | 9.33 | 10,000 | 93,300 | 10,000 | |
| May 16 2016 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| May 09 2016 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
| May 09 2016 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Buy | M | 0.00 | 5,000 | 0 | 63,333 | 58.3 K to 63.3 K (+8.57 %) |
| May 05 2016 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.39 | 830,000 | 323,700 | 830,000 | |
| May 05 2016 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Grant | A | 0.00 | 737,000 | 0 | 7,897,373 | 7.2 M to 7.9 M (+10.29 %) |
| Mar 08 2016 | ONCS.D | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Mar 08 2016 | ONCS.D | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | A | 2.02 | 12,500 | 25,250 | 547,500 | |
| Oct 19 2015 | ONCS.D | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Buy | P | 4.36 | 10,000 | 43,590 | 10,000 | 0 to 10 K |
| Aug 24 2015 | ONCS.D | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | A | 5.67 | 500,000 | 2,835,000 | 500,000 | |
| Aug 19 2015 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.28 | 355,000 | 99,400 | 355,000 | |
| May 08 2015 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | A | 8.01 | 7,500 | 60,075 | 7,500 | |
| May 08 2015 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Mar 04 2015 | ONCS.D | ONCOSEC MEDICAL In ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.37 | 250,000 | 92,500 | 250,000 | |
| Jan 19 2005 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Option Exercise | A | 3.82 | 150,000 | 573,000 | 150,000 | |
| Oct 14 2004 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Buy | P | 2.56 | 6,600 | 16,896 | 60,187 | 53.6 K to 60.2 K (+12.32 %) |
| Oct 14 2004 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Buy | P | 2.55 | 400 | 1,020 | 53,587 | 53.2 K to 53.6 K (+0.75 %) |
| Oct 14 2004 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Buy | P | 2.44 | 3,000 | 7,320 | 53,187 | 50.2 K to 53.2 K (+5.98 %) |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Option Exercise | P | 8.80 | 1,029 | 9,055 | 1,029 | |
| Sep 15 2004 | GEB | INOVIO PHARMACEUTI ... | DHILLON AVTAR S | President & CEO | Buy | P | 11,764.70 | 2 | 23,529 | 2 | 0 to 2 |
Page: 1